While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...

CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods Administration (TGA) has granted approval for mRESVIA® (mRNA-1345), ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Researchers at the University of Cologne have found that mRNA-based COVID-19 vaccines have a lasting impact on the innate ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...

Quantoom Biosciences and DIANT Pharma Inc. Collaborate to Enhance mRNA Supply Chain Efficiency Quantoom Biosciences and DIANT Pharma Inc. are proud to announce a strategic collaboration to advance the ...

Researchers at the University of Cologne and University Hospital Cologne have determined that the novel mRNA-based COVID-19 ...

Researchers have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against potential ...

A genetic mutation in horses that would typically halt protein production has become a molecular asset. Researchers at Johns ...

Researchers at the University of Cologne and University Hospital Cologne have shown in their study that the novel mRNA-based ...

Yet today, at what should be a celebration of this revolutionary technology’s potential, we find ourselves wondering about the future of mRNA research. The scientific community is watching if funding ...

A new study has found that messenger RNA can travel between different stem cells and reprogram human cells to an earlier ...